Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
1. The recently isolated compound methyllycaconitine (MLA) is a plant toxin which is a competitive inhibitor of nicotinic acetylcholine receptors (nAChRs). We found that homomeric alpha 7 receptors display a very high sensitivity to MLA with an IC50 in the picomolar range. 2. The competitive nature of the alpha 7 MLA blockade was reinforced by the observation that this compound has no action on wild-type serotoninergic receptors (5-HT3), whereas it is a powerful antagonist of chimaeric receptors alpha 7-5-HT3. 3. The time course of MLA inhibition of the wild-type (WT) alpha 7 follows a monotonic exponential decay whose time constant is proportional to the MLA concentration and could be described by a bimolecular mechanism with a forward rate constant (k+) of 2.7 x 10(7) S-1 M-1. In contrast, recovery from MLA inhibition displays an S-shaped time course that is incompatible with a simple bimolecular reaction. 4. Given the pentameric nature of the neuronal nicotinic receptors, a linear chain model, including five putative MLA binding sites corresponding to the homomeric nature of alpha 7, is proposed. 5. Both onset and recovery data obtained on the alpha 7 wild-type receptor are adequately described by this model assuming that a single MLA molecule is sufficient to block receptor function. 6. Analysis of MLA blockade and recovery of reconstituted heteromeric alpha 4 beta 2 receptors reveals, as expected, a time course compatible with only two binding sites for the toxin and, thus, further supports the validity of our model.
Alkondon,
Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist.
1992, Pubmed
Alkondon,
Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist.
1992,
Pubmed
Anand,
Pharmacological characterization of alpha-bungarotoxin-sensitive acetylcholine receptors immunoisolated from chick retina: contrasting properties of alpha 7 and alpha 8 subunit-containing subtypes.
1993,
Pubmed
Balice-Gordon,
Long-term synapse loss induced by focal blockade of postsynaptic receptors.
1994,
Pubmed
Bertrand,
Physiological properties of neuronal nicotinic receptors reconstituted from the vertebrate beta 2 subunit and Drosophila alpha subunits.
1994,
Pubmed
,
Xenbase
Catterall,
Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes.
1980,
Pubmed
Chiappinelli,
Actions of snake venom toxins on neuronal nicotinic receptors and other neuronal receptors.
1985,
Pubmed
Chiappinelli,
Kappa-bungarotoxin blocks nicotinic transmission at an identified invertebrate central synapse.
1989,
Pubmed
Clarke,
Nicotinic receptors in mammalian brain: localization and relation to cholinergic innervation.
1993,
Pubmed
Cooper,
Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor.
1991,
Pubmed
Couturier,
A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX.
1990,
Pubmed
,
Xenbase
de la Garza,
Kappa-bungarotoxin blockade of nicotine electrophysiological actions in cerebellar Purkinje neurons.
1989,
Pubmed
Eiselé,
Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities.
1993,
Pubmed
,
Xenbase
Elgoyhen,
Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells.
1994,
Pubmed
,
Xenbase
Ellinor,
Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin.
1994,
Pubmed
,
Xenbase
Groebe,
Irreversible inhibition of nicotinic acetylcholine receptors by the bipinnatins. Toxin activation and kinetics of receptor inhibition.
1994,
Pubmed
Gross,
Transfer of the scorpion toxin receptor to an insensitive potassium channel.
1994,
Pubmed
,
Xenbase
Kreienkamp,
Glycosylation sites selectively interfere with alpha-toxin binding to the nicotinic acetylcholine receptor.
1994,
Pubmed
Kukel,
Delphinium alkaloids as inhibitors of alpha-bungarotoxin binding to rat and insect neural membranes.
1994,
Pubmed
Loring,
Characterization of nicotinic receptors in chick retina using a snake venom neurotoxin that blocks neuronal nicotinic receptor function.
1989,
Pubmed
Puchacz,
Functional expression of nicotinic acetylcholine receptors containing rat alpha 7 subunits in human SH-SY5Y neuroblastoma cells.
1994,
Pubmed
,
Xenbase
Role,
Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels.
1992,
Pubmed
Sargent,
The diversity of neuronal nicotinic acetylcholine receptors.
1993,
Pubmed
Wallace,
Protein incorporation by isolated amphibian oocytes. 3. Optimum incubation conditions.
1973,
Pubmed
,
Xenbase
Ward,
Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites.
1990,
Pubmed
Weber,
Binding of Naja nigricollis (3H)alpha-toxin to membrane fragments from Electrophorus and Torpedo electric organs. 3. Effects of local anaesthetics on the binding of the tritiated alpha-neurotoxin.
1974,
Pubmed
Weber,
Binding of Naja nigricollis (3H)alpha-toxin to membrane fragments from Electrophorus and Torpedo electric organs. II. Effect of cholinergic agonists and antagonists on the binding of the tritiated alpha-neurotoxin.
1974,
Pubmed
Weber,
Binding of Naja nigricollis (3H)alpha-toxin to membrane fragments from Electrophorus and Torpedo electric organs. I. Binding of the tritiated alpha-neurotoxin in the absence of effector.
1974,
Pubmed
